*This product has been discontinued! *
| Full Name |
EPHA3 (aa569-983)
|
Abbreviated Name-1 |
EPHA3 (aa569-983); |
|
Description |
Human EPHA3,amino acids G569-V983 (as in GenBank entry NM_005233)*, N-terminally fused to GST-HIS6-Thrombin cleavage site
Sequence may contain documented polymorphisms Detailed sequence on request.
|
Source |
Baculovirus infected Sf9 cells. |
M.W. |
Theoretical MWFusion Protein: 75,680 Da. |
Specific Activity |
184 pmol/µg×min. |
Storage |
50 mM Tris-HCl, pH 8.0; 100 mM NaCl, 5 mM DTT, 4 mM reduced glutathione, 20% glycerol. -80°C, avoid repeated freeze-thaw cycles!
|
Concentration |
0.140 µg/µl(Bradford method using BSA [Sigma, cat# A-7638, Lot 79H7641] as standard protein).
|
 |
1 |
Custom Recombinant Protein Services: Guaranteed E. coli Expression Package-3 mg purified soluble protein from $2,200 . |
2 |
Bacterial Expression System: GenScript has developed BacPowerTM technologies to tackle hard-to-express and hard-to-dissolve proteins. |
3 |
Yeast Expression System: GenScript's proprietary YeastHIGHTM technology combines the advantages of the bacterial and eukaryotic expression systems. |
4 |
Baculovirus/Insect Cell Expression System: GenScript developed BacuVanceTM platform for the secretion of recombinant proteins from baculovirus-infected insect cells. |
5 |
Mammalian Cell Expression System: The proprietary 293 and CHO suspension system platform promotes fast production and delivery of recombinant proteins and monoclonal antibodies up to grams level. |
|
Document-MSDS: 12135_20100308213410.PDF (PDF)